Back to search

University of Southampton

Design of a cell-based in vitro assay for the pharmaceutical potency testing of botulinum neurotoxin type-A

Abstract

dc:description.abstract

Botulinum Neurotoxin type-A (BoNT-A), from the bacterium Clostridium Botulinum is extensively used in the pharmaceutical and medical industries for the treatment of limb dystonia and various spastic movement disorders. Determining the batch potency before release for clinical and therapeutic use is thus fundamental and is currently calculated using the mouse LD50 potency bioassay. Pursuing in vitro alternatives is vital for the replacement, refinement and reduction of animals in research (NC3R’s), and if an alternative is available, it should prioritise the animal method. Human induced pluripotent stem cells and neuroblastoma cell lines are sensitive to BoNT-A and this project screens cell lines for toxin sensitivity with the intention of selecting the most sensitive candidate for use in a GMP-compliant routine laboratory assay for the testing of potency. BoNT-A proteolytically degrades SNAP-25₂₀₆, to yield SNAP-25₁₉₇, thus inhibiting neurotransmitter release and the detection of this cleaved protein determines toxin activity. This project has successfully discovered a cell line for use in an in vitro assay demonstrating that the cells are viable for use after 7 days of growth and incubation in toxin for 48-hours provides the most optimum results. Several cell lines were screened, differentiation methods trialled and iCell Neurons, which do not require an extensive or variable differentiation protocol have been selected as the most sensitive. The method in which the SNAP-25 cleavage as a result of toxin activity is detected proved to be challenging, with the three methods originally selected as potentially sensitive rendering inconclusive or unsuitable results. Western Blot was a viable tool in the selection of the cell line, but this variable method is not a suitable GMP-compliant method for the reliable testing of such a potent and dangerous drug product.

Degree

thesis:*
Name dc:type.qualificationname
Ph.D.
Level dc:type.qualificationlevel
doctoral
Grantor dc:publisher.institution
University of Southampton
Year dc:date.issued
2018

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Davies (Long), Shellie
Advisor dc:contributor.advisor
  • Willaime-Morawek, Sandrine
ORCID person:identifier.orcid

Rights

Language dc:language
English, eng

Chain of custody

source
Harvested from
University of Southampton
Base URL
eprints.soton.ac.uk/cgi/oai2
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Davies (Long), Shellie. Design of a cell-based in vitro assay for the pharmaceutical potency testing of botulinum neurotoxin type-A. doctoral thesis, University of Southampton, 2018.